Vetoquinol Sa operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vetoquinol Sa with three other
pharmaceutical manufacturers in Europe:
sales of 26.76 billion Russian Rubles [US$472.59 million]
(885.38 million Bulgarian Lev [US$508.55 million]
of which 51%
was Tablets), and
Dechra Pharmaceuticals PLC
based in the United Kingdom
(£247.56 million [US$321.93 million]
of which 76%
was European Pharmaceuticals).
During the year ended December of 2016, sales at
Vetoquinol Sa were 350.40 million Euro (US$393.71 million).
increase of 2.3%
versus 2015, when the company's sales were 342.61 million Euro.
This was the fifth consecutive year of sales increases at Vetoquinol Sa
(and since 2011, sales have increased a total of 23%).